(3.236.121.117)
Users online: 2054    [ij] [ij] [ij] 
Email id
 

RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY
Year : 2020, Volume : 13, Issue : 12
First page : ( 6291) Last page : ( 6294)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.01094.X

CNS and COVID-19: Neurological symptoms of hospitalized patients with coronavirus in Iraq: A surveying case sequences study

Kuser Abbas Kinbar1*, Tarar Sagban Marja2, Kassid Omar Mansib3, Zayer Nael Hussein4

1College of Medicine, University of Misan, Iraq

2Otolaryngology CABS, Iraq

3College of Medicine, University of Misan, Iraq

4Al-Sadder Teaching Hospital, Iraq

*Corresponding Author E-mail: abbas_kinbar1@yahoo.com

Online published on 15 February, 2021.

Abstract

Background: At the end of the year 2019 and exactly in December, several unsolved pneumonia suitcases happened in Wuhan, China and has quickly feast to further shares of the Chinese area, formerly to (EU, USA, and Asia). The outburst was established designate affected by a novel coronavirus. Aim of the study: to determine neurological symptoms of patients suffering from COVID-19. Patients and Methods: One hundred and seven patients attended to the research laboratory established severe acute respiratory syndrome from coronavirus infection. Information we remembered from 30 January 2020 to 21 March 26, 2020. Medical information was taken from electrical medicinal archives and studied by a skilled group of medical doctors. Neurological indicators descent into three groups: (1) diseases of the central nervous system (headache; dizziness; acute cerebrovascular disease; impaired consciousness; ataxia; and epilepsy) (2) signs and symptoms of the Peripheral nervous system (hypogeusia; hyposmia; hypoplasia; and neuralgia) (3) And symptoms of skeletal muscles. The neurologists were rechecked all Information of all neurological symptoms. Results: 107 patients deliberate, 44 (41.10%) were severe and 63 (58.90%) were mild patients. Matched with mild and severe patients were elder (58.70±15.00 years vs 48.90±14.70 years),had extra fundamental illnesses (42 [47.70%] vs 41 [32.50%]), particularly HTN (16 [36.40%] vs 9 [15.10%]), and exhibited a smaller amount characteristic indicators for example fever (20[45.50%] vs 46 [73.0%]) and cough (15[34.10%] vs 38 [61.10%]). Thirty-nine (36.40%) patients with symptoms of neurologic appearance. Additionally, severe patients with neurologic manifestations (20 [45.50%] vs 19 [30.20%]), for example CVA illness (3[5.70%] vs 1 [0.80%]), diminished awareness (6 [14.80%] vs 1[2.40%]) and injury of skeletal muscle (8[19.30%] vs 3[4.80%]). Conclusion: Matched with mild patients suffering from coronavirus; severe patients had neurologic manifestation established as acute CVA, awareness diminishing, and skeletal muscle manifestations.

Top

Keywords

COVID-19, Neurological symptoms, Acute CVA.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
597,760,880 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.